1. Home
  2. ALKS vs MC Comparison

ALKS vs MC Comparison

Compare ALKS & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • MC
  • Stock Information
  • Founded
  • ALKS 1987
  • MC 2007
  • Country
  • ALKS Ireland
  • MC United States
  • Employees
  • ALKS N/A
  • MC N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • MC Investment Managers
  • Sector
  • ALKS Health Care
  • MC Finance
  • Exchange
  • ALKS Nasdaq
  • MC Nasdaq
  • Market Cap
  • ALKS 5.4B
  • MC 5.0B
  • IPO Year
  • ALKS 1991
  • MC 2014
  • Fundamental
  • Price
  • ALKS $33.02
  • MC $58.35
  • Analyst Decision
  • ALKS Buy
  • MC Hold
  • Analyst Count
  • ALKS 13
  • MC 7
  • Target Price
  • ALKS $39.50
  • MC $71.83
  • AVG Volume (30 Days)
  • ALKS 1.7M
  • MC 1.2M
  • Earning Date
  • ALKS 04-30-2025
  • MC 04-23-2025
  • Dividend Yield
  • ALKS N/A
  • MC 4.46%
  • EPS Growth
  • ALKS 3.47
  • MC N/A
  • EPS
  • ALKS 2.17
  • MC 1.93
  • Revenue
  • ALKS $1,557,632,000.00
  • MC $1,194,545,000.00
  • Revenue This Year
  • ALKS N/A
  • MC $28.67
  • Revenue Next Year
  • ALKS $4.37
  • MC $17.37
  • P/E Ratio
  • ALKS $15.10
  • MC $30.28
  • Revenue Growth
  • ALKS N/A
  • MC 39.75
  • 52 Week Low
  • ALKS $22.90
  • MC $46.24
  • 52 Week High
  • ALKS $36.45
  • MC $82.89
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 42.12
  • MC 32.67
  • Support Level
  • ALKS $33.22
  • MC $59.67
  • Resistance Level
  • ALKS $34.45
  • MC $63.95
  • Average True Range (ATR)
  • ALKS 0.96
  • MC 1.84
  • MACD
  • ALKS -0.23
  • MC 0.29
  • Stochastic Oscillator
  • ALKS 28.87
  • MC 24.97

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Share on Social Networks: